Astronics Corporation Announces First Quarter 2024 Financial Results Conference Call and Webcast
EAST AURORA, N.Y.–(BUSINESS WIRE)–Astronics Corporation (Nasdaq: ATRO), a leading provider of advanced technologies for global aerospace, defense and... Read more.
ADvendio Accelerates Its Tech Product Roadmap, Launching a Raft of New Features to Optimize Retail Media Campaign Performance
NEW YORK–(BUSINESS WIRE)–ADvendio, the leading omnichannel retail media advertising platform, has today announced a series of new features, which will... Read more.
Australia Consumer Telco Forecast & Outlook, Featuring Mobile, Fixed Broadband Revenue and Subscribers Shares for Key Telstra, Optus, TPG Telecom, NBN, Aussie Broadband, Uniti, Superloop and Amaysim – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Australia Consumer Telco Forecast & Outlook 2023” report has been added to ResearchAndMarkets.com’s... Read more.
Golub Capital BDC, Inc. Announces Preliminary Fiscal Year 2024 Second Quarter Financial Results and Declares Fiscal Year 2024 Third Quarter Distribution of $0.39 Per Share
NEW YORK–(BUSINESS WIRE)–Golub Capital BDC, Inc., a business development company (Nasdaq: GBDC), today announced estimated financial results for its... Read more.
Zydus launches Mirabegron Extended-Release Tablets in the US
AHMEDABAD, India–(BUSINESS WIRE)–#Mirabegronextendedreleasetablets–Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter... Read more.
CACI Awarded $1.3 Billion Task Order to Provide Communications and Information Technology Expertise to U.S. European Command and U.S. Africa Command
RESTON, Va.–(BUSINESS WIRE)–CACI International Inc (NYSE: CACI) announced today that it has been awarded a five-year task order worth a total estimated... Read more.
Coya Therapeutics to Participate in the Mizuho Neuroscience Summit
HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics... Read more.
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Approximately 33% of all non-small cell lung cancer patients in East Asia are never smokers – a growing and unaddressed patient population. Dr. Yashushi Goto a... Read more.
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
EMBLAVEO® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients... Read more.
Accenture Debuts Global Creative Campaign Spotlighting Stories of Reinvention
“Reinvented with Accenture” showcases company’s transformative work with clients across industries worldwide NEW YORK–(BUSINESS WIRE)–Accenture... Read more.